Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Perform® Humeral System - Fracture Study (PFX)

NCT: NCT05773352 · ACTIVE_NOT_RECRUITING

NCT IDNCT05773352
StatusACTIVE_NOT_RECRUITING
Start Date2023-08-31
Completion2034-09-01

Brief Summary

This study is an international, single arm, multicenter, prospective follow-up, non-significant risk, Post-Market Clinical Follow-up (PMCF), which is designed to collect safety and performance data on commercially available Perform® Fracture. Data collected from this study will be used for purposes, including but not limited to, PMS, peer-reviewed publications, education materials, future regulatory submissions, and/or product development.

Frequently Asked Questions

What is Perform® Humeral System - Fracture Study (PFX)?

Perform® Humeral System - Fracture Study (PFX) is a clinical trial registered under NCT05773352. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT05773352?

The current status of NCT05773352 (Perform® Humeral System - Fracture Study (PFX)) is: ACTIVE_NOT_RECRUITING.

When did Perform® Humeral System - Fracture Study (PFX) start?

Perform® Humeral System - Fracture Study (PFX) started on 2023-08-31.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.